Gilead Sciences Inc (GILD)

Lima
Currency in USD
110.25
0.00(0.00%)
Closed·
GILD Scorecard
Full Analysis
Has raised its dividend for 10 consecutive years
Trading near 52-week High
Fair Value
Day's Range
110.25110.25
52 wk Range
69.47110.25
Key Statistics
Edit
Prev. Close
110.25
Open
110.25
Day's Range
110.25-110.25
52 wk Range
69.47-110.25
Volume
-
Average Volume (3m)
74
1-Year Change
45.39%
Book Value / Share
15.37
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GILD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Gilead Sciences Inc News & Analysis

Show more

Gilead Sciences Inc Company Profile

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Employees
17600
Market
Peru

Compare GILD to Peers and Sector

Metrics to compare
GILD
Peers
Sector
Relationship
P/E Ratio
22.6x−2.7x−0.5x
PEG Ratio
0.020.040.00
Price/Book
7.0x1.0x2.6x
Price / LTM Sales
4.7x53.4x3.0x
Upside (Analyst Target)
-262.7%52.6%
Fair Value Upside
Unlock6.3%8.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.78%
Dividend Yield
2.87%
Industry Median 1.70%
Annualised payout
3.16
Paid quarterly
5-Years Growth
+3.82%
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
1.81 / 1.77
Revenue / Forecast
6.67B / 6.78B
EPS Revisions
Last 90 days

GILD Income Statement

FAQ

What Is the Gilead Sciences Inc (GILD) Stock Price Today?

The Gilead Sciences Inc stock price today is 110.25.

What Stock Exchange Does Gilead Sciences Inc Trade On?

Gilead Sciences Inc is listed and trades on the Lima Stock Exchange stock exchange.

What Is the Stock Symbol for Gilead Sciences Inc?

The stock symbol for Gilead Sciences Inc is "GILD."

Does Gilead Sciences Inc Pay Dividends? What’s The Current Dividend Yield?

The Gilead Sciences Inc dividend yield is 2.87%.

What Is the Gilead Sciences Inc Market Cap?

As of today, Gilead Sciences Inc market cap is 134.97B.

What Is Gilead Sciences Inc's Earnings Per Share (TTM)?

The Gilead Sciences Inc EPS (TTM) is 4.78.

When Is the Next Gilead Sciences Inc Earnings Date?

Gilead Sciences Inc will release its next earnings report on 04 Aug 2025.

From a Technical Analysis Perspective, Is GILD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Gilead Sciences Inc Stock Split?

Gilead Sciences Inc has split 0 times.

How Many Employees Does Gilead Sciences Inc Have?

Gilead Sciences Inc has 17600 employees.

What is the current trading status of Gilead Sciences Inc (GILD)?

As of 21 Jun 2025, Gilead Sciences Inc (GILD) is trading at a price of 110.25, with a previous close of 110.25. The stock has fluctuated within a day range of 110.25 to 110.25, while its 52-week range spans from 69.47 to 110.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.